Jul 17, 2025   SOURCE: PR NewsWire

Real Labs, Actual Decisions With Actionable Six Sigma Metrics

QuidelOrtho Announces Featured ADLM Session

SAN DIEGO, July 17, 2025 /PRNewswire/ -- How can actionable, Six Sigma insights improve lab performance? In a featured session at the Association for Diagnostics & Laboratory Medicine (ADLM) meeting, QuidelOrtho Corporation (Nasdaq: QDEL) ("QuidelOrtho") and a panel of experts will share how QuidelOrtho's Six Sigma tools and real lab data can drive quality outcomes.

ADLM Session Details:

      Session Title:          Real Labs, Real Decisions with Actionable Six Sigma Metrics



     When:          
            Tuesday, July 29, 2025


      Where:         
            McCormick Convention Center

                     
            Chicago, IL

                     
            Exhibit Hall, Theater 1



     Time:          
            2:45 p.m. - 3:45 p.m. CT


      Registration:           Space is limited. ADLM attendees can register for the
                               session using
                      this link: https://www2.na-ma.quidelortho.com/25-adlm-
                      workshop-subscribe
                      Media registered for ADLM - please reach out to Nikki
                      Wheeler to
                     access the session at Nikki.Wheeler@QuidelOrtho.com

Real Labs, Real Decisions With Actionable Six Sigma Metrics Panelists:

Dr. Jared Jaeger
Clinical Science Liaison
QuidelOrtho
Moderator

Dr. Bremansu Osa-Andrews
Medical Director of Clinical
Chemistry and Clinical Assistant Professor
University of Florida PathLab

Gilles Attipoe
Director of Laboratory Services
St. Peter's University Hospital

Angela Armato
Core Lab Manager
United Health Services and UHS Hospitals

To learn more about Six Sigma and the value of using real-world data listen to "Sigma Metrics and the Value of Real World Evidence." In this podcast, QuidelOrtho data scientist Johanna Miller discusses how Six Sigma metrics are being adapted for the clinical laboratory.

Unable to attend ADLM? Register to watch a recording of the session: https://www2.na-ma.quidelortho.com/25-adlm-workshop-subscribe.

About QuidelOrtho
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in vitro diagnostics, developing and manufacturing intelligent solutions that transform data into understanding and action for more people in more places every day.

Offering industry-leading expertise in immunoassay and molecular testing, clinical chemistry and transfusion medicine, bringing fast, accurate and reliable diagnostics when and where they are needed-from home to hospital, lab to clinic.

Building on its long history of innovation, QuidelOrtho works with global healthcare customers to advance diagnostics, where insights and solutions seamlessly connect, illuminating a clearer path for informed decisions.


     
                Investor Contact:                    Media Contact:


     Juliet Cunningham                  
     D. Nikki Wheeler


     Vice President, Investor Relations   Senior Director, Corporate
                                            Communications


     
                IR@QuidelOrtho.com                   Media@QuidelOrtho.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/real-labs-actual-decisions-with-actionable-six-sigma-metrics-302507241.html

SOURCE QuidelOrtho Corporation